expand/collapse risk warning

CFDs come with a high risk of losing money rapidly due to leverage. 71% of accounts lose money when trading CFDs with this provider. You should understand how CFDs work and consider if you can take the risk of losing your money.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

79% of retail investor accounts lose money when trading CFDs with this provider.

Loading...

Johnson And Johnson Stock (JNJ.US): Live Price Chart

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]

About

History

Differences between Investing vs Trading

About

History

Differences between Investing vs Trading

Johnson & Johnson is a global healthcare company that offers a wide range of products and services in the pharmaceutical, medical device, and consumer health industries. The company's products are sold in more than 175 countries around the world. Johnson & Johnson has over 250,000 employees worldwide. The company's operations are organized into three business segments: Pharmaceuticals, Medical Devices, and Consumer Health.

Johnson & Johnson's pharmaceutical business is focused on the discovery, development, and commercialization of medicines for the treatment of a number of diseases and conditions. The company's medical device business provides a range of products used in the diagnosis, treatment, and prevention of various medical conditions. Johnson & Johnson's consumer health business provides a range of over-the-counter and prescription medications, as well as health and wellness products.

Johnson and Johnson is one of the world's largest healthcare companies. The company's share price has seen a lot of ups and downs over the years, but has generally trended upwards over time. Recently, the company has been in the news for its involvement in the opioid crisis. Despite this, Johnson and Johnson remains a powerful force in the healthcare industry. Also members of the US 30 Industrial Average, S&P 100, and SPX500 stock market indices.

The company's share price reached its highest point in before COVID-19 in February of 2020, when it hit $151.89 per share. The stock then fell sharply in the wake of the COVID-19 pandemic, but has since recovered then reached the new highest in $186.01 per share in April 2022. The company has a strong track record of growth and profitability, and is expected to continue perform well in the future if it can navigate the upcoming challenges.

There are a few key differences between investing in and trading Johnson and Johnson shares via CFDs. When you invest in a company, you are buying shares in that company and become a part-owner. This entitles you to a portion of the company's profits, through dividends, and voting rights at shareholder meetings. When you trade JNJ shares via CFDs, you don't own the underlying asset and therefore don't receive any dividends or voting rights.

However, you can benefit from both rising and falling markets, as you can trade JNJ shares both long and short. CFD trading also allows you to use leverage, meaning you can trade with a much smaller capital outlay than if you were buying the shares outright. This can magnify your profits, but also your losses, so it's important to use leverage cautiously.

Loading
Swap long [[ data.swapLong ]] points
Swap short [[ data.swapShort ]] points
Spread min [[ data.stats.minSpread ]]
Spread avg [[ data.stats.avgSpread ]]
Min contract size [[ data.minVolume ]]
Min step size [[ data.stepVolume ]]
Commission and Swap Commission and Swap
Leverage Leverage
Trading Hours Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

Create a Skilling account
By continuing you are accepting the Privacy and Cookie policies.

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

  • Trade 24/5
  • Minimum margin requirements
  • No commission, only spread
  • Fractional shares available
  • Easy to use platform

*Other fees may apply.

Sign up

FAQs

Which are the competitors of Johnson and Johnson shares?

+ -

Johnson and Johnson shares compete with a number of other companies in the healthcare and consumer goods sectors. Some of their main competitors include Procter and Gamble, Merck, and Pfizer. While each company has its own unique products and services, they all compete for market share in the industries they operate in.

Johnson and Johnson shares have been performing well in recent years, but their competitors are always looking to gain ground. Procter and Gamble is one of the largest consumer goods companies in the world and has a large portfolio of healthcare products. Merck is a major player in the pharmaceutical industry and has a number of blockbuster drugs. Pfizer is another big name in the pharmaceutical industry with a number of well-known products.

While all of these companies are large and have significant resources, Johnson and Johnson shares still compete fiercely with them. This is because they have a strong brand and a loyal customer base. They also have a diversified product portfolio that gives them exposure to different markets.

Who owns most Johnson and Johnson shares?

+ -

The majority of Johnson and Johnson shares are owned by institutional investors. As of September 2022, the top five institutional shareholders were Vanguard Group Inc., SSgA Funds Management, Inc., BlackRock Inc., Geode Capital Management LLC and Northern Trust Investments, Inc. Vanguard Group Inc. owned approximately 8.83% of Johnson and Johnson shares, while SSgA Funds Management, Inc. owned 5.37%. BlackRock Inc. owned 4.99%, Geode Capital Management LLC owned 1.78% and Northern Trust Investments, Inc. owned 1.29%.

The top five individual shareholders of Johnson and Johnson were executive chairman Alex Gorsky, Joaquin Duato, Paulus Stoffels, Jennifer Taubert and CFO Joseph J. Wolk. Gorsky owned 3.2 million shares, while Duato owned one million shares. Stoffels owned 872,000 shares and Taubert owned 454,000 shares. Wolk owned just over 100,000 shares. These five shareholders owned a combined 14.28% of Johnson and Johnson shares.

Do Johnson and Johnson pay dividends?

+ -

Yes, Johnson and Johnson (JNJ) have been paying dividends since 1973. The company has a long history of dividend growth, having increased its payout for 49 consecutive years. JNJ is currently a Dividend Aristocrat, meaning it is one of a select group of companies that have increased their dividends for at least 25 consecutive years. This allows shareholders to reinvest their dividends to purchase additional shares of JNJ stock, without having to pay any brokerage fees. JNJ has a dividend yield of 2.63%, which is higher than the average dividend yield of the SPX500 index.

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.

CFDs
Equities
chart-long.svg

Capitalise on rising prices (go long)

green-check-ico.svg
green-check-ico.svg
chart-short.svg

Capitalise on falling prices (go short)

green-check-ico.svg
leverage-ico.svg

Trade with leverage
Hold larger positions than the cash you have at your disposal

green-check-ico.svg
trade-ico.svg

Trade on volatility
No need to own the asset

green-check-ico.svg
commissions-ico.svg

No commissions
Just low spreads

green-check-ico.svg
risk-ico.svg

Manage risk with in-platform tools
Ability to set take profit and stop loss levels

green-check-ico.svg